Educational Credits

Continuing Medical Education Credit for the Genetics and Genomics Review Course

This activity has been planned and implemented by the American College of Medical Genetics and Genomics in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. 

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

CME Credit Designation for Onsite

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 23 hours in AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

CME Credit Designation for Live Streaming

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 21.5 hours in AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Continuing Education Units (Clinical Laboratory Scientists, Directors, and Personnel)
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program. ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.®. This activity has been approved for 23 contact hours onsite and the live streaming video for a maximum 21.5 contact hours.

The onsite course ID #20-724520 is registered with CEBroker.
The live streaming course ID #20-724530 is registered with CEBroker.

National Society of Genetic Counselors (NSGC)

The National Society of Genetic Counselors (NSGC) has authorized ACMG to offer up to 2.3 CEUs or 23 Category 1 contact hours for the activity 2019 ACMG Genetics and Genomics Review Course. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

Please note that participation via live stream offers a maximum of 21.5 contact hours.


Continuing Medical Education Credit for Foundational Specialty Training

 

Continuing Medical Education Credit

This activity has been planned and implemented by the American College of Medical Genetics and Genomics in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. 

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

CME Credit Designation

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 9 hours in AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Continuing Education Units (Clinical Laboratory Scientists, Directors, and Personnel)
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program. ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.®. This activity has been approved for 9 contact hours. The onsite course ID # 20-661907 is registered with CEBroker.

NSGC credit is not offered for this course.

 

Financial Disclosures

It is the policy of the American College of Medical Genetics and Genomics to plan and implement all of its educational activities in accordance with the ACCME Essentials and Areas and ACCME® Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME® Standards for Commercial Support, everyone (speakers, moderators, contributors, committee members, and staff) who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Disclosure must include financial relationships of the individual and those of their spouse/partner. Individuals who do not disclose will be disqualified from participating in a CME activity.

This disclosure pertains to relationships with ACCME-defined commercial interests whose products or services may be related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be managed prior to the educational activity.

The following have reported disclosures:

Julie Gastier-Foster, PhD, FACMG
Dr. Gastier-Foster receives grant support from NCI Cancer Genomics, Bristol Myers Squibb and Incyte Corporation.

Bruce R. Korf, MD, PhD, FACMG
Dr. Korf is a consultant for SpringWorks and AstraZeneca. He is on the Advisory Board for Genome Medical and Envision Genomics. He is on the Board of Directors for the American College of Medical Genetics and Genomics and the Children’s Tumor Foundation. He is an advisor for the Neurofibromatosis Therapeutic Acceleration Project, a Founding Member of Envision Genomics. He is the editor for the American Journal of Human Genetics.

Elaine Lyon, PhD, FACMG
Dr. Lyon is a consultant for Genoox and is on the Board of Directors for the American College of Medical Genetics and Genomics.

Catharine Rehder, PhD, FACMG
Dr. Rehder receives grant support from NICHD. She is a consultant with Illumina and her spouse is a consultant with McKesson. She is a member of the Board of Directors for the American College of Medical Genetics and Genomics and the American Cytogenomics Conference.

 

The following planner and faculty members, staff and contributors have nothing to disclose:

Gerard Berry, MD, FACMG

Miriam G. Blitzer, PhD, FACMG

Adrian Dubuc, PhD, FACMG

Gerald Feldman, MD, PhD, FACMG

Pamela L. Flodman, MSc, MS, LCGC

Gary S. Gottesman, MD, FAAP, FACMG

Fady M. Mikhail, MD, PhD, FACMG

John A. Phillips, III, MD, FACMG

Sharon Plon, MD, PhD, FACMG

Jane Radford, MHA, CHCP (ACMG Staff)

Cindy Vnencak-Jones, PhD, FACMG

Mike Watson, PhD, FACMG

Louise E. Wilkins-Haug, MD, PhD, FACMG

Anthony J. Wynshaw-Boris, MD, PhD, FACMG

 


HIPAA COMPLIANCE

The ACMG supports medical information privacy.  While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized.  All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information.  If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the ACMG HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available on request.

 

Content Validation

ACMG follows the ACCME policy on Content Validation for CME activities, which requires:

 

Content Validation and Fair Balance

  1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
  1. All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.

 

  1. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
  2. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality.  If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.

 

 

Disclaimer:

This review course is designed as an educational resource for medical geneticists and other health care providers.  Its use does not, and should not be considered to ensure a successful outcome on the certification examinations offered by the American Board of Medical Genetics and Genomics or the American Board of Genetic Counseling, or any other examinations.  The course should not be considered inclusive of all appropriate information or all available sources of information that may be useful in preparing for the examinations or for any other purpose.

 

The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or test, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.